Promoters hold 45.8% of Senores Pharmaceuticals Limited (SENORES). FIIs hold 6.6%, mutual funds 6.6% and other DIIs 3.2%. 2.8% of the promoter holding is pledged. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Dec 24 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 45.8% | 45.8% | 45.8% | 45.8% | 45.8% | 45.8% | 45.8% | 45.8% |
| FII | 6.6% | 3.6% | 3.4% | 4.3% | 3.7% | 4.2% | 4.3% | 5.5% |
| MF | 6.6% | 5.1% | 4.9% | 3.5% | 3.0% | 3.2% | 5.0% | 5.6% |
| Other DII | 3.2% | 4.5% | 4.4% | 5.1% | 6.5% | 6.4% | 6.8% | 13.0% |
| Retail & others | 37.8% | 40.9% | 41.5% | 41.3% | 41.0% | 40.4% | 38.2% | 30.1% |
| Pledge | 2.8% | 1.9% | 1.9% | — | — | — | — | — |
No bulk or block deals disclosed for this stock in the last 90 days.
Bulk deals are uncommon for large caps — a single client has to trade over 0.5% of the company's shares in one day. Most weeks, none happen.
In Jun 26, FII holding rose +3.0pp and mutual funds +1.5pp, while retail trimmed −3.1pp. Rising institutional ownership is often read as “smart money” accumulation — though it’s never a guarantee.
Quarterly shareholding patternas of Jun 26
